NCT05465434View on ClinicalTrials.gov

Study to Evaluate the Possible Antifibrotic Effect of Zinc Sulphate in Chronic HCV Patient Receiving Direct Acting Anti-viral Therapy.

PHASE3CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

January 1, 2023

Study Completion Date

August 30, 2023

Conditions

Hepatitis C

Interventions

DRUG

Zinc Supplement

Zinc sulphate 50 mg

Trial Locations (1)

Unknown

National Liver Institute, Shibīn al Kawm

All Listed Sponsors

lead

Tanta University

OTHER